Endonovo Therapeutics Enters into $10 million Equity Line Agreement with Cavalry Fund
26. Mai 2020 08:18 ET
|
Endonovo Therapeutics, Inc.
Agreement Provides Flexible Access to Funding at a Lower Cost of Capital Los Angeles, CA, May 26, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company")...